WKA
BMY icon

Wilson Kemp & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Wilson Kemp & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,650
Closed -$323K – 31
2014
Q2 		$323K Sell
6,650
-10,010
-60% -$493K 1.16% 37
2014
Q1 		$865K Sell
16,660
-2,759
-14% -$147K 2.25% 13
2013
Q4 		$1.03M Sell
19,419
-8,741
-31% -$445K 1.98% 17
2013
Q3 		$1.3M Sell
28,160
-21,845
-44% -$959K 2.87% 10
2013
Q2 		$2.23M Buy
+50,005
New +$2.17M 2.14% 13

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wilson Kemp & Associates's BMY Position: Q3 2014 in Review

Wilson Kemp & Associates sold out of Bristol-Myers Squibb (BMY) in Q3 2014, closing a stake of 6,650 shares — an estimated $323K sold.

Wilson Kemp & Associates first reported a position in BMY in Q2 2013 and held it in 5 quarters. The position peaked at $2.23M in Q2 2013. 1,303 funds tracked by Wall St. Rank hold BMY as of Q3 2014.

  • Wilson Kemp & Associates reported no remaining Bristol-Myers Squibb position as of Q3 2014 after selling out during the quarter.
  • Wilson Kemp & Associates sold 6,650 Bristol-Myers Squibb shares in Q3 2014, an estimated $323K.
  • Wilson Kemp & Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 5 quarters.
  • Wilson Kemp & Associates's Bristol-Myers Squibb position peaked at $2.23M in Q2 2013.
  • 1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2014.

Based on Wilson Kemp & Associates's 13F filing for Q3 2014, filed 20 Oct 2014.